Clinical Trials Sponsored by Fairbanks Institute

Total 74557 results

National Cancer Institute (NCI)

Completed

Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer

Stomach Cancer | Gastric Cancer

United States
National Cancer Institute (NCI)

Completed

Maternal and Umbilical Cord Hormone Concentrations in Twin and Singleton Pregnancies

Normal Pregnancy

United States
National Cancer Institute (NCI)

Completed

Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide

Common Variable Immunodeficiency | Primary T-cell Immunodeficiency Disorders

United States
National Cancer Institute (NCI)

Terminated

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Hemophilia | AIDS

United States
National Cancer Institute (NCI)

Completed

Message Testing for Tobacco-Related Corrective Statements

Smoking | Communication | Tobacco

United States
National Cancer Institute (NCI)

Completed

Genetic Analysis of Patients With Pseudoxanthoma Elasticum

Pseudoxanthoma Elasticum | PXE

United States
National Cancer Institute (NCI)

Completed

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

Sarcoma | Lymphoma | Neuroblastoma | Wilm's Tumor

United States
National Cancer Institute (NCI)

Completed

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

Head and Neck Cancer | Laryngeal Cancer | Oral Cancer | Carcinoma, Squamous | Pharyngeal Cancer

United States
National Eye Institute (NEI)

Terminated

Family Studies of Uveal Coloboma

Coloboma

United States
National Cancer Institute (NCI)

Terminated

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Leukemia | Multiple Myeloma | MDS | Non-Hodgkins Lymphoma | Hodgkins Lymphoma

United States
National Cancer Institute (NCI)

Completed

AZD7451 for Recurrent Gliomas

Glioblastoma Multiforme

United States
National Cancer Institute (NCI)

Completed

Chordoma Family Study

Chordoma

United States
National Cancer Institute (NCI)

Completed

Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease

Cancer | HIV

United States
National Cancer Institute (NCI)

Terminated

Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma

Neoplasms | Mycosis Fungoides | Cutaneous T-Cell Lymphoma

United States
National Cancer Institute (NCI)

Completed

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

Non-Small Cell Lung Cancer (Stage III) | Colon Cancer (Stage II &Amp; III) | Rectal Cancer (Stage III)

United States
National Cancer Institute (NCI)

Withdrawn

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

Diffuse, Large B-cell Lymphoma | Lymphoma, Diffuse Large-Cell | Lymphoma, Diffuse Large-Cell B-cell | Large-Cell Lymphoma, Diffuse
National Cancer Institute (NCI)

Completed

Community Cancer Centers Pilot Patient Survey

Cancer | Malignant Neoplasms

United States
National Cancer Institute (NCI)

Completed

Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients

Fungus Disease

United States
National Cancer Institute (NCI)

Completed

BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Cell Lines From High-Risk Breast Tissue

Healthy

United States
National Cancer Institute (NCI)

Withdrawn

Imaging Studies and the Development of Multiple Myeloma

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma
National Cancer Institute (NCI)

Completed

Radiation Exposure and Thyroid Disease in Kazakhstan

Thyroid Cancer | Thyroid Nodules | Other Thyroid Disease

Kazakhstan
National Cancer Institute (NCI)

Completed

Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing

Thyroid Cancer

Kazakhstan
National Cancer Institute (NCI)

Completed

Methods in Education for Breast Cancer Genetics

Breast Cancer | Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma

HIV Infections | HIV Seropositivity | Kaposi's Sarcoma

United States
National Eye Institute (NEI)

Completed

Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases

Corneal Dystrophies, Hereditary | Corneal Disease

United States, China, Italy
National Cancer Institute (NCI)

Completed

A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province

Precancerous Gastric Lesions

China
National Cancer Institute (NCI)

Completed

PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

Squamous Cell Carcinoma

United States
National Cancer Institute (NCI)

Withdrawn

A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas

Astrocytoma | Glioblastoma Multiforme | Ependymoma | PNET | Brainstem Glioma
National Cancer Institute (NCI)

Completed

Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

Lung | Brain | Breast | Prostate | Endometrial

United States
National Cancer Institute (NCI)

Completed

An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer

Metastatic Melanoma | Renal Cell Cancer

United States
National Cancer Institute (NCI)

Completed

Comparison of Two Dose Assessment Methods for Exposures to Nuclear Detonation Radiation

Radiation Exposure

United States
National Cancer Institute (NCI)

Completed

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Hepatocellular Carcinoma | Biliary Tract Neoplasms | Liver Cancer | Biliary Cancer | Heptocellular Cancer

United States
National Cancer Institute (NCI)

Terminated

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer

Metastatic Cancer | Metastatic Melanoma | Renal Cancer

United States
National Cancer Institute (NCI)

Completed

Perspective-taking, and Examining the Clinical Trial Informed Consent Process

Emotions | Informed Consent

United States
National Cancer Institute (NCI)

Completed

Evaluation of National Cancer Institute Young Adult Stop-Smoking Program

Smoking | Smoking Cessation | Cigarette Smoking | Tobacco, Smoking

United States
National Eye Institute (NEI)

Completed

People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial

Retinoschisis | X-Linked

United States
National Cancer Institute (NCI)

Terminated

Enzastaurin to Treat Recurrent Brain Tumor

Glioma

United States
National Cancer Institute (NCI)

Completed

Safety of Batracylin in Patients With Solid Tumors and Lymphomas

Neoplasms

United States
National Eye Institute (NEI)

Completed

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Macular Degeneration

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

Ovarian Neoplasms | Fallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer
National Cancer Institute (NCI)

Terminated

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

Mesothelioma

United States
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR)

Completed

Rubidium-82 - An Alternative Radiopharmaceutical for Myocardial Imaging(Rb-ARMI) (Rb-ARMI)

Coronary Artery Disease

Canada
National Cancer Institute (NCI)

Completed

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

Neoplasms | Lymphoma

United States
National Cancer Institute (NCI)

Terminated

Biomarker Analysis of Central Nervous System Tumors

Central Nervous System Neoplasms | Brain Cancer | Neoplasms, Brain | Primary Brain Neoplasms | Cancer of the Brain

United States
National Cancer Institute (NCI)

Completed

EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial

Gastric Cancer

United States
National Cancer Institute (NCI)

Completed

Genetic Predictors of Cardiovascular Disease

Cardiovascular Disease

United States
National Cancer Institute (NCI)

Terminated

Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer

Prostate Cancer

United States

Clinical Trials Sponsored by Fairbanks Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations